MS PathwaysSM provides free reimbursement counseling and assistance with insurance coverage to people on BETASERON. Help and support are available.
Get a printable doctor-patient discussion guide to help prepare you for speaking with your healthcare professional about choosing a disease-modifying therapy.
Paying for Your BETASERON
Being newly diagnosed with MS can be overwhelming. But taking control of the financial aspects of your treatment with BETASERON doesn't have to be. We're available to offer support and counseling through MS PathwaysSM to help lessen your financial concerns.
Reimbursement Service
The BETASERON Reimbursement Service, which is part of MS PathwaysSM, offers consultation to help address your insurance concerns and explain your options. BETASERON is often covered by health insurance plans.
The counselors specialize in a range of topics to help you:
- Determine your pharmacy benefits
- Seek prior authorization for your medication, if necessary
- Handle appeals and other coverage issues
Free overnight shipping to your home
If your insurance company does not already provide this service, MS PathwaysSM will. BETASERON can be sent—via free overnight shipping—to you, anywhere within the United States.
Receive a complimentary Betaject® 3.
The Betaject® 3 is an auto-injection device specifically designed to work with BETASERON as an optional injection method for BETASERON. If you choose to begin BETASERON therapy, you will receive your personal Training Kit and your complimentary Betaject® 3 to help get you started.
Betaject® 3 is a registered trademark of Bayer HealthCare Pharmaceuticals Inc.
Betaject® 3 is manufactured by Owen Mumford Ltd.
BETASERON® (Interferon beta-1b) is indicated for the treatment of relapsing forms of multiple sclerosis to reduce the frequency of clinical exacerbations. Patients with multiple sclerosis in whom efficacy has been demonstrated include patients who have experienced a first clinical episode and have MRI features consistent with multiple sclerosis.
Important Safety Information
The most commonly reported adverse reactions are lymphopenia, injection-site reaction, asthenia, flu-like symptom complex, headache and pain. Gradual dose titration and use of analgesics during treatment initiation may help reduce flu-like symptoms. BETASERON should be used with caution in patients with depression. Injection-site necrosis has been reported in 4% of patients in controlled trials. Patients should be advised of the importance of rotating injection sites. Female patients should be warned about the potential risk to pregnancy. Cases of anaphylaxis have been reported rarely. See "Warnings," "Precautions," and "Adverse Reactions" sections of full Prescribing Information.
